3 Penny Stocks On UK Exchange With Market Caps Under £3M

The United Kingdom's FTSE 100 index recently experienced a downturn, influenced by weak trade data from China, highlighting the interconnected nature of global markets. Amid such volatility, investors often seek opportunities in smaller or newer companies that can offer growth potential despite broader market challenges. Penny stocks, although a somewhat outdated term, remain relevant as they can provide surprising value when backed by strong financial health.

Top 10 Penny Stocks In The United Kingdom

Name	Share Price	Market Cap	Financial Health Rating
ME Group International (LSE:MEGP)	£2.085	£785.55M	★★★★★★
Begbies Traynor Group (AIM:BEG)	£0.924	£145.75M	★★★★★★
Secure Trust Bank (LSE:STB)	£3.39	£64.65M	★★★★☆☆
Ultimate Products (LSE:ULTP)	£1.165	£99.53M	★★★★★★
Luceco (LSE:LUCE)	£1.28	£197.41M	★★★★★☆
Stelrad Group (LSE:SRAD)	£1.38	£175.75M	★★★★★☆
Next 15 Group (AIM:NFG)	£3.86	£383.9M	★★★★☆☆
Integrated Diagnostics Holdings (LSE:IDHC)	$0.45	$261.6M	★★★★★★
Tristel (AIM:TSTL)	£3.90	£186M	★★★★★★
Impax Asset Management Group (AIM:IPX)	£2.41	£307.94M	★★★★★★

Click here to see the full list of 472 stocks from our UK Penny Stocks screener.

Let's dive into some prime choices out of the screener.

PHSC (AIM:PHSC)

Simply Wall St Financial Health Rating: ★★★★★★

Overview: PHSC plc, with a market cap of £2.16 million, operates through its subsidiaries to offer health, safety, hygiene, and environmental consultancy services as well as security solutions to both public and private sectors in the United Kingdom.

Operations: The company's revenue is derived from various segments, including £1.12 million from Security Division - B2BSG Systems LTD, £0.768 million from Systems Division - QCS International LTD, and a combined total of £1.811 million across its Health & Safety Division subsidiaries: Inspection Services (UK) LTD (£0.253 million), RSA Environmental Health LTD (£0.368 million), Quality Leisure Management LTD (£0.345 million), and Personnel Health & Safety Consultants LTD (£0.845 million).

Market Cap: £2.16M

PHSC plc, with a market cap of £2.16 million, demonstrates financial stability by having short-term assets (£1.4M) that surpass both short-term (£627K) and long-term liabilities (£148K). Despite being debt-free for the past five years, recent earnings show a net loss of £0.012 million for the half-year ending September 2024, compared to a net income the previous year. The company's profit margins have declined from 7.6% to 3.1%, and it faces negative earnings growth (-55.7%). Leadership changes include CEO Stephen King's resignation, with Lorraine Young stepping in as non-executive Chair amid ongoing executive transitions.

• Click here to discover the nuances of PHSC with our detailed analytical financial health report.
• Review our historical performance report to gain insights into PHSC's track record.

Westmount Energy (AIM:WTE)

Simply Wall St Financial Health Rating: ★★★★☆☆

Overview: Westmount Energy Limited is a venture capital firm focusing on providing seed capital to small and medium-sized companies, with a market cap of £1.15 million.

Operations: Westmount Energy Limited does not report any revenue segments.

Market Cap: £1.15M

Westmount Energy Limited, with a market cap of £1.15 million, is pre-revenue and currently unprofitable, reporting a net loss of GBP 0.745734 million for the year ending June 2024. Despite having no debt and short-term assets (£278.7K) exceeding liabilities (£50.8K), the company faces challenges with high share price volatility and less than a year of cash runway based on current free cash flow trends. The experienced board offers stability, but losses have increased by 31.9% annually over five years, highlighting ongoing financial hurdles in its venture capital pursuits within the energy sector.

• Get an in-depth perspective on Westmount Energy's performance by reading our balance sheet health report here.
• Assess Westmount Energy's previous results with our detailed historical performance reports.

Oscillate (OFEX:MUSH)

Simply Wall St Financial Health Rating: ★★★★☆☆

Overview: Oscillate plc is a venture capital and private equity firm focusing on special situations and growth capital investments in fledgling companies, with a market cap of £1.21 million.

Operations: Oscillate plc has not reported any revenue segments.

Market Cap: £1.21M

Oscillate plc, with a market cap of £1.21 million, is a pre-revenue venture capital firm focusing on growth capital investments. The company remains unprofitable and has seen losses increase by 10.6% annually over the past five years. Despite being debt-free and having short-term assets (£2.2M) that cover both short-term (£41.7K) and long-term liabilities (£23.1K), Oscillate's high share price volatility poses risks for investors in the penny stock realm. The board's average tenure of 2.2 years suggests relative inexperience, which may impact strategic decision-making as they navigate special situations investments.

• Unlock comprehensive insights into our analysis of Oscillate stock in this financial health report.
• Explore historical data to track Oscillate's performance over time in our past results report.

Make It Happen

• Discover the full array of 472 UK Penny Stocks right here.
• Got skin in the game with these stocks? Elevate how you manage them by using Simply Wall St's portfolio, where intuitive tools await to help optimize your investment outcomes.
• Unlock the power of informed investing with Simply Wall St, your free guide to navigating stock markets worldwide.

Curious About Other Options?

• Explore high-performing small cap companies that haven't yet garnered significant analyst attention.
• Jump on the AI train with fast growing tech companies forging a new era of innovation.
• Find companies with promising cash flow potential yet trading below their fair value.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com